NEW YORK (GenomeWeb News) – German molecular diagnostics company Epigenomics reported today that its first-quarter revenues increased 46 percent year over year.

For the three months ended March 31, total revenues were €355,000 ($468,000), up from €243,000 in the first quarter a year ago.

Its product sales increased to €163,000 from €125,000 a year ago, while R&D service income shot up to €126,000 from €4,000. Licensing revenues were down to €66,000 from €114,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.